Subutex 300 mg injektionsvätska, depotlösning, Subutex 100 mg injektionsvätska, depotlösning clinical trials

A Phase IV Longitudinal Study of SUBLOCADE (SUBUTEX Prolonged Release) Clinical Outcomes in Adults with Opioid Use Disorder (Opioid Dependence)

This study looks at how well SUBLOCADE, a long-acting injection, helps adults with opioid use disorder. It aims to see if people achieve and maintain recovery over 3 years while using this treatment, checking for symptom improvement and other important health outcomes.